Representative dot plots and histograms illustrate significantly different levels of CD14+CD16- monocytes (Figure 2A), lineage negative and B cells (Figure 2B), CD8+ naïve and CD8+ CM T cells (Figure 2C), and DN (CD4-CD8-CD3+) T cells (Figure 2D) in NSCLC patients compared to healthy volunteers at baseline. This evidence concerns the gene CD8A and non-small cell lung carcinoma.